Decoy Therapeutics Inc. Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent
Decoy Therapeutics Inc. (DCOY) reported Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent · last filed 2026-03-31
- Decoy Therapeutics Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2025 was 0.00%.
- Decoy Therapeutics Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2018 was -1.60%.
- Decoy Therapeutics Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2017 was -1.30%.
- Decoy Therapeutics Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2016 was -0.10%, a 125.00% decline from fiscal 2015.
| Period end | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month |
|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-31 |
| 2018-12-31 | -1.60% 10-K · filed 2019-03-06 |
| 2017-12-31 | -1.30% 10-K · filed 2019-03-06 |
| 2016-12-31 | -0.10% 10-K · filed 2019-03-06 |
| 2015-12-31 | 0.40% 10-K · filed 2018-03-07 |
| 2014-12-31 | 0.00% 10-K · filed 2017-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |